ABH Healthcare IPO GMP & Allotment
ABH Healthcare operates a 150-bed multi-specialty tertiary care hospital in Ferozepur, Punjab, under the brand “Anil Baghi Hospital.” The company focuses on providing a wide range of healthcare services, including advanced clinical care across approximately 25 specialties. Core disciplines include cardiac sciences, neurology, minimally invasive spine and brain surgeries, gastroenterology, orthopedics, and joint replacement. The hospital generates revenue through a mix of in-patient and out-patient services, supported by a network of over 30 public and private insurance companies and TPAs. Operations are supported by a robust infrastructure that includes an in-house pharmacy, a pathology laboratory, and advanced medical equipment. The business model is centered on delivering comprehensive and accessible medical care, from emergency services and critical care to specialized treatments, to the community in and around the Tier-3 city of Ferozepur.
- IPO Price Band
- ₹96.00 - ₹102.00
- Lot Size
- 1,200 Shares
- Bidding Closes
- 26 Aug 2026
- Listing Date
- 31 Aug 2026
ABH Healthcare IPO GMP Today & Key Takeaways
The Grey Market Premium (GMP) for ABH Healthcare IPO is currently awaiting trading updates (last quote: ₹0). The shares are offered in the price band of ₹96.00 - ₹102.00 per share, with a minimum retail investment of Rs 2,44,800 for 1,200 Shares. Public bidding has closed. The basis of allotment is expected on 27 Aug 2026, ahead of stock exchange listing on 31 Aug 2026.
| Key Metric | Figure | Status / Context |
|---|---|---|
| Current GMP | ₹0 | +0% vs upper band (27 Aug 2026) |
| Est. Listing Price | Est. ₹102 | +0.00% Est. Listing Gain |
| Price Band | ₹96.00 - ₹102.00 | SME IPO |
| Retail Minimum Investment | ₹2,44,800 | 2 Lot (1,200 Shares) |
| Bidding Window | 24 Aug 2026 – 26 Aug 2026 | Closed |
| Allotment & Listing Dates | Allotment: 27 Aug 2026 | Listing: 31 Aug 2026 |
Complete IPO information
| IPO Open Date | 24 Aug 2026 |
|---|---|
| IPO Close Date | 26 Aug 2026 |
| IPO Price Band | ₹96.00 - ₹102.00 |
| Lot Size | 1,200 Shares |
| Current GMP | ₹0 |
| Estimated Listing Gain | +0.00% |
| Issue Size | Approx ₹34.98 Cr |
| Fresh Issue | - |
| Issue Type | SME |
| IPO Listing | NSE SME |
| Retail Quota | TBA |
| Registrar | TBA |
| Overall Subscription | 1.44x |
| Minimum Investment | ₹2,44,800 |
| DRHP Draft Prospectus | |
| RHP Draft Prospectus | - |
Subscription Status
| Category | Shares Reserved | Shares Applied | Subscription (x) |
|---|---|---|---|
| QIB | 1.99 | 16.67 | 8.37xx |
| NII | 1.71 | 4.37 | 0.29xx |
| Retail | 15.29 | 25.78 | 1.69xx |
| Overall Subscription | 34.3 | 46.81 | 1.44xx |
IPO Snapshot & Investor Takeaways
At the upper end of its price band, ABH Healthcare is priced at ₹102 per share. With a minimum lot size of 1,200 shares, a retail investor applying for one lot would need approximately ₹2,44,800 to participate in this SME issue.
The latest recorded Grey Market Premium for ABH Healthcare stands at ₹0, implying an estimated listing gain of around 0.00% over the issue price if it holds until listing. GMP reflects informal grey-market sentiment rather than a guaranteed outcome, and can change at any point until the day of listing.
As of the latest update, ABH Healthcare's IPO was subscribed 1.44x overall, with a category-wise breakdown of Retail 1.69x, QIB 8.37x, NII 0.29x.
Among the strengths highlighted in ABH Healthcare's IPO documents: Doctor-led professional management team with proven execution capabilities.; Track record of delivering quality clinical care by attracting and retaining renowned clinicians..
Investors should also weigh the risk factors ABH Healthcare has disclosed, including: Significant dependency on key personnel, including promoters and healthcare professionals..
A share of ABH Healthcare's issue proceeds is earmarked for Repayment Of Borrowings: 17 (48.60%).
SME IPOs list on the dedicated SME platform of BSE/NSE. They usually involve smaller issue sizes and a higher per-lot investment than Mainboard issues, with comparatively lower institutional participation.
IPO roadmap at a glance
| Event / Milestone | Scheduled Date | Status |
|---|---|---|
| Bidding Opens | 24 Aug 2026 | Completed |
| Bidding Closes | 26 Aug 2026 | Completed |
| Allotment | 27 Aug 2026 | Next Milestone |
| Listing | 31 Aug 2026 | Pending |
Daily GMP status
| Date | GMP | Change | Gain |
|---|---|---|---|
| 27 Aug 2026 | ₹0.00 | - | TBA |
| 26 Aug 2026 | ₹0.00 | - | TBA |
| 25 Aug 2026 | ₹0.00 | - | TBA |
| 24 Aug 2026 | ₹0.00 | - | TBA |
| 19 Aug 2026 | ₹0.00 | - | 0.00% |
Application size breakdown
| Category | Lots | Shares | Amount |
|---|---|---|---|
| Retail Minimum | 2 Lot | 2,400 | ₹2,44,800 |
| Retail Maximum | 2 Lot | 2,400 | ₹2,44,800 |
| S-HNI Minimum | 3 Lot | 3,600 | ₹3,67,200 |
| S-HNI Maximum | 8 Lot | 9,600 | ₹9,79,200 |
| B-HNI Minimum | 9 Lot | 10,800 | ₹11,01,600 |
Objects of the Issue & Official Documents
- Repayment Of Borrowings 17 (48.60%)
- Working Capital 5 (14.29%)
- General Corporate Purpose 12.98 (37.11%)
Important takeaways before applying
Strengths
- Doctor-led professional management team with proven execution capabilities.
- Track record of delivering quality clinical care by attracting and retaining renowned clinicians.
- Diversified operations across multiple clinical specialties, payor mix, and hospitals.
- Robust operating infrastructure, including modern information technology and medical equipment.
- Consistent track record of stable operating and financial performance and growth.
Risks
- Significant dependency on key personnel, including promoters and healthcare professionals.
- Revenues are significantly dependent on a single hospital located in Ferozepur, Punjab.
- Inability to keep pace with technological changes and new equipment may adversely affect business.
- Business is subject to legal claims and regulatory actions arising from healthcare services.
- The company does not own the premises for its hospital, which operates on a leasehold basis.
ABH Healthcare IPO Reservation
The ABH Healthcare IPO reservation is divided among Qualified Institutional Buyers (QIBs), Non-Institutional Investors (NIIs), Retail Individual Investors and other applicable categories.
As per the provided allocation, 1,99,200 shares are offered to Qualified Institutional Buyers excluding anchor investors. The NII category is allocated 15,28,800 shares, representing approximately 44.58%, while Retail Individual Investors are also offered 15,28,800 shares, representing approximately 44.58% of the issue.
| Investor Category | Shares Offered | Shares (%) |
|---|---|---|
| Anchor Investor | – Shares | -% |
| QIB (Ex. Anchor) | 1,99,200 Shares | -% |
| NII Shares Offered | 15,28,800 Shares | 44.58% |
| Retail Shares Offered | 15,28,800 Shares | 44.58% |
ABH Healthcare IPO Dates
The ABH Healthcare IPO will open for subscription on August 24, 2026 and close on August 26, 2026. Investors can submit their IPO applications during this three-day subscription period.
The ABH Healthcare IPO allotment is expected to be finalized on August 27, 2026. Refunds for unsuccessful applicants and credit of shares to successful investors' demat accounts are scheduled for August 28, 2026. The shares are scheduled to list on the NSE SME platform on August 31, 2026.
| IPO Event | Date |
|---|---|
| IPO Open Date | August 24, 2026 |
| IPO Close Date | August 26, 2026 |
| Basis of Allotment | August 27, 2026 |
| Refunds | August 28, 2026 |
| Credit to Demat Account | August 28, 2026 |
| IPO Listing Date | August 31, 2026 |
ABH Healthcare IPO Dates
| Particular | Dates |
|---|---|
| IPO Open Date | 24 Aug 2026 |
| IPO Close Date | 26 Aug 2026 |
| Basis of Allotment | 27 Aug 2026 |
| Refunds | - |
| Credit to Demat Account | - |
| IPO Listing Date | 31 Aug 2026 |
Note: The timeline for ABH Healthcare IPO is tentative and subject to change.
ABH Healthcare IPO Objects of the Issue & Utilisation of Proceeds
ABH Healthcare proposes to utilise the proceeds from the fresh issue primarily towards repayment or prepayment of existing borrowings and funding the company's working capital requirements. The remaining proceeds are proposed to support inorganic growth opportunities and general corporate purposes.
The company intends to utilise approximately ₹17.00 crores towards repayment or prepayment, in part or full, of certain borrowings. Another ₹4.30 crores is proposed to be utilised towards working capital requirements to support the company's ongoing healthcare operations.
| Purpose | Amount |
|---|---|
| Repayment / prepayment, in part or full, of certain borrowings | ₹17.00 Cr. |
| Funding the Company's Working Capital Requirements | ₹4.30 Cr. |
| Funding inorganic growth through unidentified acquisitions and general corporate purposes | ₹- |
ABH Healthcare Objects of the Issue & Utilisation of Proceeds
To Be Updated Soon
ABH Healthcare IPO Company Financial Report
ABH Healthcare reported steady revenue growth between FY2024 and FY2026. Revenue increased from ₹41.39 crores in FY2024 to ₹49.32 crores in FY2025 and further reached ₹52.59 crores in FY2026.
The company's profitability improved more significantly over the same period. Profit After Tax (PAT) increased from ₹1.66 crores in FY2024 to ₹5.35 crores in FY2025 and ₹5.64 crores in FY2026. Total assets also expanded from ₹51.35 crores in FY2024 to ₹85.27 crores in FY2026.
| Period Ended | Revenue | Expense | PAT | Assets |
|---|---|---|---|---|
| 2024 | ₹41.39 Cr. | ₹39.19 Cr. | ₹1.66 Cr. | ₹51.35 Cr. |
| 2025 | ₹49.32 Cr. | ₹41.89 Cr. | ₹5.35 Cr. | ₹63.90 Cr. |
| 2026 | ₹52.59 Cr. | ₹44.66 Cr. | ₹5.64 Cr. | ₹85.27 Cr. |
ABH Healthcare Company Financials
To Be Updated Soon
ABH Healthcare Company Valuation – FY2026
To Be Updated Soon
ABH Healthcare IPO Peer Group Comparison
To Be Updated Soon
Compare ABH Healthcare IPO with similar IPOs
ABH Healthcare IPO FAQs
Comments
Share a useful question or insight about ABH Healthcare.
Leave a comment
Your email address will not be published. All comments and replies are reviewed before appearing.
Loading comments...